Found: 12
Select item for more details and to access through your institution.
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2469, doi. 10.3390/ijms20102469
- By:
- Publication type:
- Article
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. 1, doi. 10.3389/fimmu.2021.670088
- By:
- Publication type:
- Article
CD33‐directed immunotherapy with third‐generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33‐edited acute myeloid leukemia and hematopoietic stem and progenitor cells.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 7, p. 1141, doi. 10.1002/ijc.33865
- By:
- Publication type:
- Article
Conversion of Methane to Methanol on Cobalt-Embedded Graphene: A Theoretical Perspective.
- Published in:
- Catalysis Letters, 2022, v. 152, n. 5, p. 1331, doi. 10.1007/s10562-021-03742-1
- By:
- Publication type:
- Article
Clinical and genetic characteristics of pyridoxine-dependent epilepsy: Case series report of three Chinese patients with phenotypic variability.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 14, n. 3, p. 1989, doi. 10.3892/etm.2017.4735
- By:
- Publication type:
- Article
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.670088
- By:
- Publication type:
- Article
Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.608167
- By:
- Publication type:
- Article
Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 2, p. 419, doi. 10.1002/ijc.33212
- By:
- Publication type:
- Article
Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 5, p. 1312, doi. 10.1002/ijc.32201
- By:
- Publication type:
- Article
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 373, doi. 10.3390/biomedicines10020373
- By:
- Publication type:
- Article
Au atoms doped in Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene: Benefiting recovery of oxygen vacancies towards photocatalytic aerobic oxidation.
- Published in:
- Nano Research, 2022, v. 15, n. 4, p. 2862, doi. 10.1007/s12274-021-3878-x
- By:
- Publication type:
- Article
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19-positive malignancies.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8121
- By:
- Publication type:
- Article